Hall v. Coram Healthcare Corp., 97-8246
| Decision Date | 15 October 1998 |
| Docket Number | No. 97-8246,97-8246 |
| Citation | 157 F.3d 1286 |
| Parties | Fed. Sec. L. Rep. P 90,301, 12 Fla. L. Weekly Fed. C 178 William J. HALL, Barbara Lisser, Individually and on behalf of all others similarly situated, Plaintiffs-Appellants, v. CORAM HEALTHCARE CORPORATION, James M. Sweeney, Patrick Fortune, Sam Leno, Defendants-Appellees. |
| Court | U.S. Court of Appeals — Eleventh Circuit |
W. Pitts Carr, Render C. Freeman, Edward A. Grossmann, Atlanta, GA, Patricia S. Gillane, Roger Kirby, Peter Linden, New York City, for Plaintiffs-Appellants.
Michael P. Kenny, Teresa D. Thebaut, Alston & Bird, Atlanta, GA, for Defendants-Appellees.
Appeal from the United States District Court for the Northern District of Georgia.
Before EDMONDSON and HULL, Circuit Judges, and CLARK, Senior Circuit Judge.
BACKGROUND
A complete account of the facts in this case is set out in In re T2 Medical, Inc. Shareholder Litigation ("In re T2 "). 1 Briefly, the appellants here were the plaintiff class members of a prior federal securities action that had resulted in a settlement with the defendants from that action, Coram Healthcare Corporation ("Coram") and two officers from a company that had merged with Coram. As part of the settlement agreement, appellants were issued over 2.5 million warrants to purchase Coram common stock at approximately $22 per share. 2 Several months after the settlement was final, Coram announced a second-quarter loss of over 66 million dollars, leading to a significant decrease in the value of the warrants. 3 Appellants alleged that during the pendency of the settlement, the defendants publicly made false and misleading statements and omitted material facts that led to an inflated price of their stock, and that they misrepresented the true financial condition and performance of the company.
Appellants filed a Motion to Enforce Stipulation of Settlement, alleging numerous claims under Georgia law and requesting damages, or, in the alternative, reformation of the settlement agreement to adjust the price of the warrants. 4 The district court denied the motion, holding that it no longer retained authority or jurisdiction over the settlement. 5 The appellants appealed that decision, but this court affirmed the district court's denial of the motion for lack of jurisdiction. 6
After filing their notice of appeal, the appellants filed this suit against Coram and several of its officers, asserting claims for violation of (1) section 10(b) of the Securities Exchange Act of 1934 (the Exchange Act), 7 and Rule 10b5; 8 (2) section 20(a) of the Exchange Act; 9 (3) state law claims of unlawful securities practices; 10 (4) state law claims of fraud by silence; 11 and (5) breach of the implied covenant of good faith and fair dealing. They sought compensatory damages and an award of damages to reflect the difference in the value of the warrants from the price in the settlement and the closing price of Coram stock on the trading day following the announcement.
The district court dismissed the complaint under Fed.R.Civ.P. 12(b)(6), finding that the settlement was a contract subject to the ordinary rules of contract construction, and that the settlement contained a merger or "entire agreement" clause. The district court relied on Georgia law holding that when the injured party sought damages rather than recission, a merger clause prevented recovery by estopping the claimant from asserting reliance on any misrepresentations or omissions made outside of the four corners of the contract. The district court found that because the plaintiffs specifically disavowed reliance on statements not included in the settlement documents, and could show no statements within the settlement documents by which they were defrauded, they failed to state a claim for securities fraud. Because the appellants could not recover any relief on their federal claims, and thus no federal jurisdiction existed, the district court dismissed the state law claims. This appeal followed.
This Court reviews de novo the dismissal of a complaint for failure to state a claim, accepting all allegations in the complaint as true and construing facts in a light most favorable to the plaintiff. 12 A complaint may not be dismissed unless it appears beyond doubt that the plaintiff cannot prove any set of facts in support of his claim which would entitle him to relief. 13
Federal securities claims
To state a cause of action under Section 10b of the Exchange Act or Rule 10b-5, plaintiffs must be able to demonstrate reliance on a material misrepresentation or omission made either directly or through fraud on the market. 14 In their complaint, the appellants alleged that the statements were made or omitted from "public statements, press releases and filings with the Securities and Exchange Commission."
Appellants argue that their claims are governed by federal securities law, not by state contract law, and that a merger clause is insufficient to bar a claim under the Exchange Act for securities fraud. During oral argument, counsel for the appellants specifically alleged that the fraud occurred after the district court's order finalizing the settlement, disavowed any claim of fraud in the inducement, and argued that because the fraud occurred after the settlement, it was not barred by the merger clause. However, the allegations of fraud in the complaint specifically and repeatedly state that the misstatements and omissions of fact comprising the fraud occurred "[p]rior to the final determination of the exercise price of the Warrants."
The problem with the argument that the fraud occurred after the settlement was final is that appellants have failed to show the reliance necessary to state a cause of action for a federal securities fraud claim. Fraud occurring after the settlement would be irrelevant to any stock purchased by the appellants through the exercise of the warrants, because the warrants' price was fixed by the settlement. The price was arrived at through negotiation, and was not set by the market. Thus, in order to establish reliance, any claim for fraud that the appellants have necessarily would have had to occur by the time the settlement was made final.
Paragraph 10.7 of the settlement provides that the "Side Letter Agreement, Stipulation and the Exhibits attached hereto constitute the entire agreement among the parties hereto and no representations, warranties or inducements have been made to any party concerning the Stipulation, the Exhibits or the Side Letter Agreement other than the representations, warranties and covenants contained and memorialized in such documents." 15 The settlement agreement also contained a paragraph preventing any modification of the settlement based on judicial decisions, changes in the financial conditions of any of the parties, any newly discovered facts, events or allegations, or any other conduct which related to the settlement or the released claim. Because the appellants allege that the statements that constituted fraud occurred outside of the settlement agreement, a cause of action could be maintained only if the merger clause in the agreement did not prohibit admission of those statements.
In a recent Supreme Court case, two suits were initiated on behalf of the stockholders of a Delaware corporation, MCA, Inc., after another corporation tendered an offer for the common stock of MCA. 16 The first suit was a class action, filed in Delaware against MCA and its directors, alleging violations of Delaware law. 17 While that action was pending the second suit was brought in California, alleging violations of Securities and Exchange Commission Rules 10b-3 and 14d-10. 18 The California district court entered summary judgment for the defendants, and the plaintiffs appealed. 19 Before the appeal was heard, the first suit was settled. 20 The settlement included a release of all claims arising out of the acquisition. 21
On appeal, the defendants/appellees invoked the Delaware judgment as a bar to further prosecution of the action, relying on the Full Faith and Credit Act, 28 U.S.C. § 1738. The Supreme Court agreed, holding that the Delaware settlement judgment was entitled to full faith and credit, notwithstanding the fact that it released claims within the exclusive jurisdiction of the federal courts.
The Court used a two-step analysis in reaching its decision. The Court first looked to state law to ascertain the rules regarding the preclusive force of class-action settlement judgments in subsequent suits. 22 The Court found that Delaware law held that the judgment barred subsequent pursuit of the claims, even though the federal securities claims could not have been pursued in the state chancery court where the first suit was filed. 23 The Court then looked to the Exchange Act, and noted that although the Act conferred exclusive jurisdiction on federal courts for suits arising under it, it neither allowed "plaintiffs with Exchange Act claims to have more than one day in court to challenge the legality of a securities transaction" ... nor prevented litigants "from voluntarily releasing Exchange Act claims in judicially approved settlements." 24
Here, Georgia law regards a settlement as a contract. 25 Merger clauses are enforceable and may prevent parties from recovering for fraud, depending on the relief sought. Georgia law is clear that plaintiffs have two options available against a defendant for alleged misrepresentations in a contract action: a plaintiff can affirm the contract and sue for damages, in which case the merger clause applies, or the plaintiff can rescind the contract and sue in tort for alleged fraud, and the merger clause does not prevent introduction of parole evidence. 26 Because the appellants affirmed the contract and sued for damages, the merger clause applies, and they are barred from introducing evidence outside the settlement documents. As the district court noted, the...
To continue reading
Request your trial
-
Worsham v. Provident Companies, Inc.
... ... Celotex Corp. v. Catrett, All U.S. 317, 322-23, 106 S.Ct. 2548, 91 ... See Hall v. Coram Healthcare Corp., 157 F.3d 1286, 1289 (11th ... ...
- Transcon. Gas Pipe Line Co. v. 6.04 Acres
-
Brogdon ex rel. Cline v. National Healthcare Corp.
...motion to dismiss, the Court considers all well-pleaded facts set forth in the plaintiff's complaint as true. Hall v. Coram Healthcare Corp., 157 F.3d 1286, 1287 (11th Cir.1998). A. Counts One and Two: The Medicare and Medicaid Plaintiffs assert claims pursuant to the Medicare and Medicaid ......
-
Dunn v. Air Line Pilots Ass'n
...it appears beyond doubt that the plaintiff can prove no set of facts which would entitle plaintiff to relief. Hall v. Coram Healthcare Corp., 157 F.3d 1286, 1288 (11th Cir. 1998); Terry v. Cook, 866 F.2d 373, 375 (11th Cir. Our review of a summary judgment order is also de novo. See Eastman......